Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
Sher
E
E
Department of Medical Pharmacology, University of Milan, Italy.
Carbone
E
E
Clementi
F
F
D000918:Antibody Specificity; D001323:Autoantibodies / Q000276:immunology*; D015220:Calcium Channels / Q000187:drug effects / Q000502:physiology*; D018288:Carcinoma, Small Cell / Q000276:immunology; D002460:Cell Line; D006801:Humans; D066298:In Vitro Techniques; D015624:Lambert-Eaton Myasthenic Syndrome / Q000276:immunology*; D008175:Lung Neoplasms / Q000276:immunology; D009419:Nerve Tissue Proteins / Q000502:physiology; D009474:Neurons / Q000276:immunology; D010455:Peptides / Q000494:pharmacology; D020866:omega-Conotoxin GVIA
D001323:Autoantibodies; D015220:Calcium Channels; D009419:Nerve Tissue Proteins; D010455:Peptides; D020866:omega-Conotoxin GVIA